Latest Breaking News On - Kate beebe devarney - Page 1 : comparemela.com

BioCorRx Reports Business Update for the First Quarter of 2024

May 16, 2024 - BioCorRx Inc. , a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the three months ended March.

United statesLourdes felixKate beebe devarneyNational institutes of health under award numberAgreement termsEnd addiction initiativeDevelopment of medications toExchange commissionBiocorrx pharmaceuticals board of directorsNational institute on drug abuseBiocorrx incBiocorrx pharmaceuticalsNational institutes of healthTrademark officeNational survey on drugBiocorrx pharmaceuticals inc

BioCorRx Pharmaceuticals Inc Appoints Neuroscientist Dr Kate DeVarney to the Board of Directors

ANAHEIM, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innov.

United statesKate beebe devarneySmithkline beechamLourdes felixWeight loss programAmerican psychiatric associationNational institute of healthTitan pharmaceuticals incNational institute on drug abuseBiocorrx pharmaceuticalsAmerican society of addiction medicineBiocorrx incCrescendo communicationsEnd addiction initiativeAgreement termsJournal of the american medical association

BioCorRx Pharmaceuticals Inc Appoints Neuroscientist Dr Kate DeVarney to the Board of Directors

BioCorRx Pharmaceuticals Inc Appoints Neuroscientist Dr Kate DeVarney to the Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSmithkline beechamLourdes felixKate beebe devarneyCrescendo communicationsNational advisory committee on drug abuseNational institute on drug abuseTitan pharmaceuticals incNational institute of healthWorld wide human health at merck coAmerican society of addiction medicineAmerican college of neuropsychopharmacologyAmerican psychiatric associationAgreement termsInternational society of addiction medicineBiocorrx pharmaceuticals

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Kate beebe devarneyTitan pharmaceuticalsSecurities exchangeExchange commissionTitan pharmaceuticals incTitan pharmaceuticals fully compliant withNasdaq stock marketNasdaq capitalSouth san franciscoSecurities actSecurities exchange actAnnual reportInvestor contactsBeebe devarneyChief operating

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria

SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 Titan Pharmaceuticals, Inc. today announced that by letter dated January 24, 2024, the Company was notified by The Nasdaq Stock Market LLC that the.

Kate beebe devarneySecurities exchangeGlobenewswire incTitan pharmaceuticals incNasdaq stock marketTitan pharmaceuticalsExchange commissionNasdaq capitalSan franciscoSecurities actSecurities exchange actAnnual reportInvestor contactsBeebe devarneyChief operating